Clinical Trial Update: Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma

View source ↗

Summary

This clinical trial update notes ongoing recruitment for a study evaluating circulating tumor DNA as a biomarker in soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Sarcoma | Status: RECRUITING